Sania Therapeutics

Online Valuation Platform

Sania Therapeutics is building precision gene therapies, combining targeted delivery of a therapeutic with a titratable activator to redefine nervous system therapies and maximize safety and efficacy.

Sania’s proprietary platform takes a “human-first” approach, recreating human neural circuits in the lab to develop cell-type specific gene delivery vectors. Sania’s system for neuromodulation normalizes electrical activity in these neural circuits, allowing them to treat a broad range of prevalent disorders.

SECTOR

Health Sciences

INVESTED

2023

STATUS

Active

HQ

London, UK

FOUNDERS

Andy Murray, PhD
Robert Brownstone, MD/PhD
Raj Dattani, BMBCh

Subscribe to hear about Arc Ventures' updates and events.